John H. Leaman - 19 Oct 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC

Role
Chief Fin. & Business Officer
Signature
/s/ John Leaman, M.D.
Issuer symbol
N/A
Transactions as of
19 Oct 2021
Net transactions value
$0
Form type
4
Filing time
21 Oct 2021, 17:31:01 UTC
Previous filing
26 Jul 2021
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Restricted Stock Units (RSUs) Award $0 +10,571 $0.000000 10,571 19 Oct 2021 Common Stock 10,571 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2 The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the reporting person's continuation of employment on such vesting date.